BRISTOL-MYERS SQUIBB COMPANY Share Repurchase Authorization
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Share Repurchase Authorization of $250.00 million as of 2023-03-31, per its 10-Q filed 2023-04-27.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2023-04-27
- 2023-03-31: Stock Repurchase Program, Authorized Amount $250.00M.
- 2021-12-31: Stock Repurchase Program, Authorized Amount $15.00B.
- 2021-09-30: Stock Repurchase Program, Authorized Amount $2.00B.
- 2021-06-30: Stock Repurchase Program, Authorized Amount $2.00B.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2023-03-31 | $250.00M 10-Q · filed 2023-04-27 |
| 2021-12-31 | $15.00B 10-K · filed 2022-02-09 |
| 2021-09-30 | $2.00B 10-Q · filed 2021-10-27 |
| 2021-06-30 | $2.00B 10-Q · filed 2021-07-28 |
| 2021-03-31 | $2.00B 10-Q · filed 2021-04-29 |
| 2021-01-31 | $2.00B 10-K · filed 2022-02-09 |
| 2020-09-30 | $5.00B 10-Q · filed 2020-11-05 |
| 2020-06-30 | $5.00B 10-Q · filed 2020-08-06 |
| 2020-03-31 | $5.00B 10-Q · filed 2020-05-07 |
| 2019-12-31 | $7.00B 10-Q · filed 2021-10-27 |
| 2016-12-31 | $3.00B 10-K · filed 2017-02-21 |
| 2016-09-30 | $3.00B 10-Q · filed 2016-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |